Daiwa Securities Group
DOVA

Daiwa Securities Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Daiwa Securities Group’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-183
Closed -$5K – 1274
2019
Q3 		$5K Buy
183
+41
+29% +$664 ﹤0.01% 1084
2019
Q2 		$2K Hold
142
– – ﹤0.01% 1167
2019
Q1 		$1K Hold
142
– – ﹤0.01% 1179
2018
Q4 		$1K Hold
142
– – ﹤0.01% 1140
2018
Q3 		$3K Hold
142
– – ﹤0.01% 1119
2018
Q2 		$4K Hold
142
– – ﹤0.01% 1115
2018
Q1 		$4K Buy
+142
New +$4.25K ﹤0.01% 1098

Daiwa Securities Group's DOVA Position: Q4 2019 in Review

Daiwa Securities Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 183 shares — an estimated $5K sold.

Daiwa Securities Group first reported a position in DOVA in Q1 2018 and held it in 7 quarters. The position peaked at $5K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Daiwa Securities Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 183 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $5K.
  • Daiwa Securities Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
  • Daiwa Securities Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $5K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.